That’s why in a special edition of our ‘Spotlight On…’ interactive broadcast series, we’ll be assessing if the popularity of probiotics in China can help boost the infant nutrition sector.
The free-to-attend broadcast, aired live on January 18, will feature expert insights spanning the very latest market trends, regulatory developments, and academic research.
Brought to you in association with our partners Morinaga, the event will feature independent insights from:
Doris Huang, Senior Food Regulatory Consultant, CIRS
As senior food regulatory consultant, Doris is familiar with the Chinese food related regulations for different food categories, including the regulations for infant formula, novel ingredients, food supplement, sports nutrition foods etc. She has been successfully consulting and provide tailored solutions for international food companies to cope with Chinese market and regulations. Doris has a Master degree in Food Quality Management from Wageningen University and a Bachelor degree in Food Quality and Safety Management from China Jiliang University.
Jane Li, Founder & Principal Consultant, Li, Page & Co.
Jane is an entrepreneur and internationally recognised China expert with 10+ years’ experience specialising in the infant formula and milk nutrition markets. She co-founded New Zealand milk marketing company Biopure Health, developing and launching white-label infant formula and milk powder brands into the China market, and led a retail expansion strategy establishing 100 franchise stores in 13 provinces culminating in a successful corporate exit in 2017. She is a trusted subject matter advisor to global consulting firms and investment management funds and is a regular contributor to New Zealand and international media.
Takane Katayama, Professor of Microbiology, Kyoto University
Takane received his Ph.D at Kyoto University in 1999. After spending three years as a postdoctoral fellow in Hidehiko Kumagai’s laboratory, he was appointed an assistant professor at Kenji Yamamoto’s lab and started the research on bacterial sugar metabolism. In early 2000s, he isolated the genes for 1,2-α-L-fucosidase and endo-α-N-acetylgalactosamindase from Bifidobacterium species, both of which are enzymes acting on human-derived glycans. The findings prompted him to consider a symbiotic relationship between gut microbes and humans via host-derived glycans. In the past decade, he has focused on functional analysis of bifidobacterial genes and enzymes responsible for degradation of human milk oligosaccharides. His research has significantly contributed to revealing how bifidobacteria-rich microbiota is formed in the gut of breast-fed infants.
Dr. Chyn Boon Wong, Lead Research Associate, Morinaga Milk Industry
Dr. Chyn Boon serves as the Lead Research Associate at the International Division of Morinaga Milk. She is responsible for expanding the global B2B business with science-backed HRB probiotic offerings. In her research, she has conducted studies on probiotic metabolites particularly those produced by human-residential bifidobacteria (HRB). Chyn Boon is keen to apply her research expertise and translate probiotics science into business innovation.
The hour-long broadcast will be hosted by NutraIngredients-Asia editor-in-chief Gary Scattergood.
He said: “Early life nutrition can inevitably affect a child’s growth and development and the gut microbiome plays a vital part in it.
“China is a major contributor to the global infant formula market. However, the once-booming market has seen growth slow due to decreasing birth rate, meaning infant formula companies are engaged in a heated race to find new growth drivers.
“Please register and join our expert speakers as they discuss the market insights, regulatory framework, and scientific basis of probiotics in infant nutrition.”
